Sign in
Deepa Hattangadiabout 1 year ago

What is the NVX-CoV2373 coronavirus disease 2019 (COVID-19) vaccine?

Top rated comment
about 1 year ago

NVX-CoV2373 (Novavax) NVX-CoV2373 (Novavax) is produced by employing nanoparticle technology. In this technology, complete genetic sequence of SARS-CoV-2 is used to generate full-length perfusion spike (S) protein which is combined with Matrix-M. Clinical trials are being conducted to conclude the efficacy and side-effects of this vaccine. Recent trials show efficient binding with human receptors. NVX-CoV2373 (Novavax) is administered as 2-dose series with difference of 21 days in between.

Other commentsSign in to post comments. Don't have an account? Sign up now!